Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-03-16

Opinion for Stryker Corp. (SYK-N)

Signal Price Bias Subject Owned
TOP PICK $131.500 UNKNOWN NORTH AMERICAN - LARGE Yes

This is known for knees and hips, and they have sold millions of knee replacement implants. They’ve recently started using a robot to replace the body parts, giving greater accuracy and lower costs. With the robot, you can only use their parts, making it a closed system. He doesn’t foresee any changes in the US health care act having an effect on this company and their equipment. Dividend yield of 1.3%. (Analysts’ price target is $132.)

Zachary Curry
Chief Operating Officer & Portfolio Manager, Davis-Rea Ltd. http://www.davisrea.com/contact/

No Comments.


You must be logged in to comment.